2024 annual financial data
Innate Pharma 2024 Operating margin
Innate Pharma 2024 operating margin with verified reported values.
Direct answer
Operating margin was -408.64%.
Operating income was -51,575,000 EUR and net income was -49,471,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,621,000 EUR
- Operating income
- -51,575,000 EUR
- Net income
- -49,471,000 EUR
- Operating cash flow
- Not available